Press Releases Search View

Select Category

Recent News

Search By:

Search By Release Date

100 Record(s) Found. Displaying Page 3:

[<< Prev] 1 2 3 4 5 [Next >>]

MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
Print \| More options ▼ View RSS Feed
Release Date: 21-Jul-10 Author or Contact:
DALLAS, July 21, 2010/PRNewswire/ -- According to the new market research report "Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)", published by MarketsandMarkets (http://www.marketsandmarkets.com), the global bioinformatics market is expected to reach a $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 ...
Click to read MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014

UNDERGRADS SURF THROUGH SUMMER DOING HANDS-ON RESEARCH AT UH
Print \| More options ▼ View RSS Feed
Release Date: 20-Jul-10 Author or Contact:
HOUSTON, July 20, 2010 - Researching how heart cells or embryos develop is not typical summertime fare for most students. At the University of Houston, however, enterprising young scientists are participating in an intensive summer program delving into any number of complex projects. Eleven students from the College of Natural Sciences and Mathematics have committed their time to the Summer Undergraduate Research Fellowship ...
Click to read UNDERGRADS SURF THROUGH SUMMER DOING HANDS-ON RESEARCH AT UH

Access Pharmaceuticals Signs Exclusive Specialty Distribution Agreement With BioScrip
Print \| More options ▼ View RSS Feed
Release Date: 20-Jul-10 Author or Contact:
Agreement Provides Multi-level Distribution Of Lead Product, Including Inventory In Over 30 Top Metro Areas DALLAS and NEW YORK, July 20 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (BULLETIN BOARD: ACCP) , a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has signed an exclusive specialty distribution agreement with BioScrip (NASDAQ:BIOS ...
Click to read Access Pharmaceuticals Signs Exclusive Specialty Distribution Agreement With BioScrip

NIH awards Rice $1.7M for cartilage-regeneration research
Print \| More options ▼ View RSS Feed
Release Date: 19-Jul-10 Author or Contact:
Bioengineers explore whether adult stem cells can help heal joints HOUSTON -- (July 19, 2010) -- Bioengineers from Rice University's BioScience Research Collaborative have won a $1.7 million grant from the National Institutes of Health to develop an injectable mix of polymers and adult stem cells that can spur the growth of new cartilage in injured knees and other joints. "Millions of people live with pain, limited ...
Click to read NIH awards Rice $1.7M for cartilage-regeneration research

Nanotubes pass acid test
Print \| More options ▼ View RSS Feed
Release Date: 14-Jul-10 Author or Contact:
Rice researchers' method untangles long tubes, clears hurdle toward armchair quantum wire HOUSTON - (July 14, 2010) - Rice University scientists have found the "ultimate" solvent for all kinds of carbon nanotubes (CNTs), a breakthrough that brings the creation of a highly conductive quantum nanowire ever closer. Nanotubes have the frustrating habit of bundling, making them less useful than when they're separated in ...
Click to read Nanotubes pass acid test

Emerging Technology Fund expects $46M from feds to cover capital shortfall Read more: Emerging Technology Fund expects $46M from feds to cover capital shortfall - Austin Business Journal
Print \| More options ▼ View RSS Feed
Release Date: 14-Jul-10 Author or Contact: Lacey Webster
A $46 million federal reimbursement check is expected to cover a capital shortfall in the Texas Emerging Technology Fund for at least the next six months, state officials said Wednesday. The additional funding from the Federal Emergency Management Agency would enable the ETF to continue funding start up companies for two quarters, possibly three, ETF Director Alan Kirchhoff said in light of projected capital shortages reported this ...
Click to read Emerging Technology Fund expects $46M from feds to cover capital shortfall Read more: Emerging Technology Fund expects $46M from feds to cover capital shortfall - Austin Business Journal

KCI launches new research division
Print \| More options ▼ View RSS Feed
Release Date: 13-Jul-10 Author or Contact:
Kinetic Concepts Inc. has established a new internal structure to promote and lead the company's research efforts in regenerative medicine, therapeutic support and wound-healing technologies. Called the Advanced Research and Technology (ART) center, the department will be made up of leading researchers and engineers who will investigate emerging medical therapies and technologies to fuel new product development and ...
Click to read KCI launches new research division

Reata raises $78M round to back pivotal kidney drug trial Read more: Reata raises $78M round to back pivotal kidney drug trial - FierceBiotech http://www.fiercebiotech.com/story/reata-raises-78m-roun
Print \| More options ▼ View RSS Feed
Release Date: 12-Jul-10 Author or Contact:
With the backing of Novo A/S, Irving, TX-based Reata Pharmaceuticals has raised a whopping $78 million round to finance a final pivotal program for a new therapy for chronic kidney disease and Type 2 diabetes. The new money brings Reata's total venture funding to $180 million. Reata's eggs have been clustered in the bardoxolone basket, a drug which activates the Nrf2 gene and improves the filtration rate of the kidneys, a ...
Click to read Reata raises $78M round to back pivotal kidney drug trial Read more: Reata raises $78M round to back pivotal kidney drug trial - FierceBiotech http://www.fiercebiotech.com/story/reata-raises-78m-roun

Vidacare appoints acting CEO, chief operating officer
Print \| More options ▼ View RSS Feed
Release Date: 12-Jul-10 Author or Contact:
Vidacare Corp. has reshuffled the company's management team as part of a strategic initiative to expand sales worldwide. Chief Financial Officer Mark Mellin has been promoted to acting CEO and president and Mike Voss has been tapped to fill the newly created position of chief operating officer. Former CEO Phil Faris will move into a new role at the company that will increase product sales internationally. San Antonio-based Vidacare ...
Click to read Vidacare appoints acting CEO, chief operating officer

New Reports on Cancer/Oncology Market July Update by MarketsandMarkets
Print \| More options ▼ View RSS Feed
Release Date: 12-Jul-10 Author or Contact:
DALLAS, July 8, 2010/PRNewswire/ -- MarketsandMarkets published new market research reports in Cancer/Oncology industry reports Global Oncology Pharmaceuticals & Therapeutics Market ( http://www.marketsandmarkets.com/Market-Reports/oncology-pharmaceuticals-ther apeutics-arket-152.html) (Due to the length of these URLs, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. ...
Click to read New Reports on Cancer/Oncology Market July Update by MarketsandMarkets

New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets
Print \| More options ▼ View RSS Feed
Release Date: 12-Jul-10 Author or Contact:
DALLAS, July 8, 2010/PRNewswire/ -- According to a new market research report, 'Emerging Markets BRIC (Brazil, Russia, India and China) Patient Monitoring Market (2010 - 2015), published by MarketsandMarkets (http://www.marketsandmarkets.com), the total BRIC patient monitoring devices market is expected to be worth US$3,075 million by 2015, and the China market is expected to account for nearly 62.9% of the total revenues. The BRIC ...
Click to read New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets

Vivante GMP Solutions Announces Expansion of Technical Staff
Print \| More options ▼ View RSS Feed
Release Date: 8-Jul-10 Author or Contact:
Vivante GMP Solutions, Inc. ("Vivante"; www.vivante-gmp.com <http://click.icptrack.com/icp/relay.php?r=24634625&msgid=370357&act=5GHP&c=630646&destination=http%3A%2F%2Fwww.vivante-gmp.com%2F> ) today announced that it has increased its technical staff in order to assist the Company in its continued growth as a leader in the virus-based biologics contract manufacturing space. Additional staff has been added in the areas of ...
Click to read Vivante GMP Solutions Announces Expansion of Technical Staff

Texas A&M Institute for Genomic Medicine awarded $12.25 million defense department contract to combat agents of biological terror
Print \| More options ▼ View RSS Feed
Release Date: 7-Jul-10 Author or Contact:
COLLEGE STATION, Texas - The Texas A&M Institute for Genomic Medicine (TIGM), a leading global source for genetic discoveries, has been selected by the Defense Threat Reduction Agency (DTRA) to identify and develop new drug targets for certain toxins, viruses and bacterial pathogens. By discovering and ultimately developing strategies to eliminate the ways in which toxins and microbes hijack cells, this research has the potential to ...
Click to read Texas A&M Institute for Genomic Medicine awarded $12.25 million defense department contract to combat agents of biological terror

UTHealth biotech incubator nears capacity Eight Texas-based startups now call TMC home
Print \| More options ▼ View RSS Feed
Release Date: 2-Jul-10 Author or Contact:
HOUSTON - (July 2, 2010) - The University of Texas Health Science Center at Houston (UTHealth) announced that its Biotechnology Commercialization Center (BCC) has leased more than three-quarters of its available space to eight Texas-based startups in less than a year. The center's focus is to assist biotech entrepreneurs and small companies with the translation of discoveries into innovative health solutions. The BCC provides ...
Click to read UTHealth biotech incubator nears capacity Eight Texas-based startups now call TMC home

SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies
Print \| More options ▼ View RSS Feed
Release Date: 30-Jun-10 Author or Contact:
HOUSTON, June 30 /PRNewswire/ -- SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm(TM) microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for ...
Click to read SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies

SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies
Print \| More options ▼ View RSS Feed
Release Date: 30-Jun-10 Author or Contact:
HOUSTON, June 30 /PRNewswire/ -- SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm(TM) microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for ...
Click to read SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies

Austin Technology Incubator picks biosciences director
Print \| More options ▼ View RSS Feed
Release Date: 28-Jun-10 Author or Contact:
The Austin Technology Incubator has appointed Cindy WalkerPeach as the new director of the Bioscience incubator, three months after its previous director stepped down. WalkerPeach was previously the director of corporate business development for Asuragen Inc., a Austin-based molecular diagnostics company that is a spinoff of Ambion Inc., where she started Ambion Diagnostics, a business unit focusing on clinical applications. ...
Click to read Austin Technology Incubator picks biosciences director

Uluru offloads acne line
Print \| More options ▼ View RSS Feed
Release Date: 28-Jun-10 Author or Contact:
Specialty pharmaceutical company Uluru Inc. said Monday the company will divest its interest in Zindaclin, a product used to treat acne. Uluru will sell its interest to a subsidiary of Crawford Healthcare Ltd. Straken International Ltd., which owns the remaining interest in Zindaclin, also will sell its interest. Uluru and Straken will split the proceeds, which are expected to be $5.1 million. Kerry Gray, ...
Click to read Uluru offloads acne line

Apollo Endosurgery Recommended for $5 Million Commercialization Award From the Cancer Prevention and Research Institute of Texas
Print \| More options ▼ View RSS Feed
Release Date: 22-Jun-10 Author or Contact:
AUSTIN, Texas, June 22 /PRNewswire/ -- Apollo Endosurgery announced today that the Company received notice of a $5 million award from the State of Texas through the Cancer Prevention and Research Institute of Texas ("CPRIT"). Apollo was one of only three companies recommended for the inaugural commercialization awards. CPRIT was established to expedite innovation and commercialization in the area of cancer research and to enhance access ...
Click to read Apollo Endosurgery Recommended for $5 Million Commercialization Award From the Cancer Prevention and Research Institute of Texas

Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
Print \| More options ▼ View RSS Feed
Release Date: 22-Jun-10 Author or Contact:
THE WOODLANDS, Texas, June 21 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, presented clinical data and analysis from its Phase 2a clinical trial of LX4211 for patients with type 2 diabetes mellitus at ENDO 2010 today. The results reported today included newly-obtained data showing a trend of increased total GLP-1 in both ...
Click to read Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes

[<< Prev] 1 2 3 4 5 [Next >>]

Contact Us | Site Map |

| OPML | Search This Site | Home
Schipul Web Design | Houston Social Media | Tendenci� Content Management Software | Privacy | Terms and Conditions